Objectives: Few studies have considered the effect of Weinberger et al.'s personality types on the management of pain. The aims of this study were to (1) identify whether the relationships between pain intensity, cognitive factors, and disability at 3 and 6 months postbaseline differ as a result of personality type; and (2) identify whether personality type affects the likelihood of achieving a minimal clinically important change in pain intensity or disability at 3 and 6 months. Method: Patients completed a set of validated questionnaires assessing personality type, cognitive factors, pain intensity, and disability at 3 and 6 months postbaseline. Results: A greater proportion of defensive high-anxious individuals reported improvement for both pain (3 months = 25%; 6 months = 38%) and disability (3 months = 35%; 6 months = 50%) and showed stronger links between improvements in pain and disability and baseline psychological factors than nonextreme individuals. Conclusions: The high proportion of defensive high-anxious individuals highlights the need for psychologically based interventions to be delivered earlier in the care process.
INTRODUCTION
Chronic pain affects approximately 14 million people in England and has a significant impact on the economy. Within the United Kingdom, back pain specifically is estimated to cost £12.3 billion per year 1 ; this is the equivalent of 22% of the annual National Health Service (NHS) budget (2014). Pain management programs (PMPs) are designed to address cognitive factors and provide patients with selfmanagement strategies in order to reduce their use of healthcare services. Successful self-management can be difficult for some individuals, while others appear able to effectively manage their condition at home, and do not need to regularly utilize healthcare services. The mechanisms behind these individual differences are poorly understood, but have been suggested to be a function of personality type. Some studies have identified differences between individuals with high or low trait anxiety, which predispose individuals to respond differently to pain-related stimuli.
2 Some of these findings are equivocal and may indicate an interaction between anxiety and other factors. The inclusion of defensiveness alongside trait anxiety (personality type) has highlighted differences in how individuals respond to treatment and health outcomes in chronic illness populations [3] [4] [5] [6] ; however, there is limited evidence within chronic musculoskeletal pain populations.
Weinberger et al. 7 proposed 4 personality profiles based on their trait scores on 2 orthogonal dimensions (trait anxiety and defensiveness): high-anxious (high trait anxiety and low defensiveness); defensive highanxious (DHA; high trait anxiety and defensiveness); low-anxious (low in both trait anxiety and defensiveness); and repressors (low trait anxiety and high defensiveness). The 4 personality profiles are believed to show different behaviors when confronted with stressful situations. DHA individuals are often omitted from studies because they are relatively rare within the general population. Within the clinical environment, however, they make up approximately 39% to 46% 8, 9 of the population. They have also been found to utilize a greater number of treatment options (eg, physiotherapist, chiropractor, doctor) compared to the other personality types, despite reporting similar levels of pain intensity and satisfaction with treatment. 10 These findings suggest that the interaction of anxiety and defensiveness may influence patients' interpretation of pain and therefore persistence within the care system.
There has been only limited research investigating the interaction between defensiveness and trait anxiety and the relationship with pain and disability. To our knowledge, our previous study was the first to demonstrate that within a DHA group, cognitive factors (catastrophizing, depression, and self-efficacy) explained 48% of the variance in disability, while pain intensity was not significantly related. Whereas within individuals who score in the midrange of anxiety and defensiveness (the nonextreme [NE] group), the reverse was true, with the cognitive factors shown to not affect the variance in disability, while pain intensity explained 36%.
11 A cross-sectional study looks at a snapshot in time, and the relationships identified in the previous study are informative; however, it is important to investigate whether these cognitive factors are predictive of outcome by tracking patients over time. A critical consideration when investigating treatment outcome is the minimal clinically important change (MCIC) of patientbased outcomes, such as pain intensity or disability. Ostelo and de Vet 12 suggested that MCIC is defined as the smallest change in an outcome measure necessary to yield a clinically important change in the health status of the patients. Currently, there is limited research that includes the MCIC, despite patient self-report being considered an important domain. The aims of this study were to (1) determine whether the personality types, as defined by Weinberger et al., 7 influenced the key relationships between pain and disability and a variety of psychological factors; and (2) identify whether personality type affects the likelihood of achieving an MCIC in pain intensity or disability at 3 and 6 months.
METHOD

Participants
Participants were recruited from their current hospitalbased PMP, which was in line with the British Pain Society guidelines. The PMPs included a psychologically based group rehabilitative intervention that was delivered once a week for 6 weeks by a physiotherapist. The aim was to improve the physical, psychological, emotional, and social dimensions of quality of life for people with chronic pain. PMPs focus on the patient's physical and psychological well-being, rather than seeking to treat a disease or biomedical problem. Similar to the National Institute for Health and Care Excellence guidelines, PMPs consist of an education element and guided practice. 13 Patients remained on their current treatment program, and no additional intervention was given.
Patients who had suffered from chronic pain for more than 3 months were given an information pack by their clinician asking them to contact the chief investigator of the study if they wished to take part. The study was approved by Manchester Metropolitan University Ethics committee and the NHS Health Research Authority, and all participants gave informed consent. Exclusion criteria were evidence of red flags (eg, specific pathologies such as cancer), diagnosis of serious spinal pathology such as malignancy and vertebral fracture, acute herniated disc with nerve root entrapment, other health conditions that prevented patients from exercising (eg, cardiac pacemaker, unstable angina, or poorly controlled cardiac problem), and under 18 years of age. Patients who had taken part in our previous study 11 were asked to complete a set of validated questionnaires at 3 and 6 months after entry into the PMP. If patients responded to the first questionnaire (baseline), they were then sent a second questionnaire at 3 months. From the baseline sample (n = 79), 58 patients responded to the second questionnaire. Patients who responded to the second questionnaire were then sent a third questionnaire 6 months postbaseline (47 responses were received). If participants had not responded to a questionnaire pack within 3 weeks, they were sent 1 reminder letter and questionnaire pack. If they did not respond to the reminder, they were assumed to have withdrawn from the study. Personality type was assessed based on criterion splits on the trait subscale of the State-Trait Anxiety Inventory (STAI) 14 and the Marlowe-Crowne Social Desirability Scale (MC-SDS). 15 were asked to rate their pain over the past 24 hours on a scale ranging from 0 (no pain) to 10 (pain as bad as could be). The 11-point NRS has been supported by previous research and has been recommended by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) to assess chronic pain intensity. 16 Defensiveness. The 10-item short form of the MC-SDS 15 was used to assess defensiveness. The scale consists of items that are culturally approved but unlikely to occur. A correlation coefficient of r = 0.9 (P < 0.001) has been reported between the 10-item MC-SDS and the original 33 item MC-SDS, 17 with an internal consistency alpha coefficient of 0.66. 18 The MC-SDS measures affect inhibition, as defensiveness has been defined as the protection of self-esteem.
17
Trait Anxiety. The trait scale of the STAI 14 was used to assess trait anxiety. The scale consists of 20 statements that participants rate on a scale of 1 (not at all) to 4 (very much so). The trait component of the STAI has a testretest reliability of between 0.73 and 0.86.
14 Catastrophizing. The Pain Catastrophizing Scale (PCS) 19 is a self-report measure of catastrophic thinking associated with pain and consists of 13 items. The PCS asks participants to reflect on their painful experiences and indicate the degree to which they experienced the 13 thoughts or feelings on a 5-point Likert scale ranging from 0 (not at all) to 4 (all the time).
Depression. The Centre for Epidemiologic Studies Depression Scale 20 is a 20-item self-report measure of depression symptoms. Each item asks participants how frequently a specific symptom was experienced in the past week, ranging from 0 (not even one day) to 3 (daily). High internal consistency has been reported with coefficient alphas ranging from 0.85 to 0.92. 20 Disability. The Roland Morris Disability Questionnaire (RDQ) 21 was used to assess disability due to pain. This is a 24-item self-report measure where participants answer either "true" or "false" to each statement about how they are feeling today. This measure has shown an acceptable level of reliability, with a correlation coefficient of 0.91 21 and internal consistency of 0.90.
22
Functional Self-Efficacy. Similar to the study of Woby, Roach, Urmston, and Watson, 23 the functional subscale of the Chronic Pain Self-Efficacy Scale 24 was used to measure functional self-efficacy. The questionnaire comprises 9 items scored on a 9-point Likert scale. Three written descriptors anchor the scale scores at 0 (totally unconfident), 4 (moderately unconfident), and 8 (totally confident). Woby et al. 25 assessed the psychometric properties of this scale and reported alpha coefficients for internal consistency of 0.88 and testretest reliability of 0.80 to 0.93.
Kinesiophobia. For the purposes of this study, the 11-item version of the Tampa Scale of Kinesiophobia  (TSK) 26 was utilized to measure fear of movement or (re)injury. Respondents rate themselves on a 4-point Likert scale ranging from "strongly agree" to "strongly disagree." The TSK demonstrates good internal consistency (a = 0.79), and test-retest reliability (intraclass correlation coefficient = 0.81).
27
Statistical Analyses
Heterogeneity checks were completed to ensure the groups differed in defensiveness and trait anxiety. An attrition analysis was performed to assess any differences between the baseline characteristics of those who completed the trials and those who dropped out by 6 months. In order to assess differences between the groups for cognitive factors, pain, and disability, repeated-measures analyses of variance (ANOVAs) were run with the between-subject factor of personality type (2: DHA, NE) and within-subject factor of time (baseline, 3 months, 6 months). Post hoc t-tests were run in order to determine any specific significant differences between the groups, and within the groups. Effect sizes are also reported. In order to identify whether the relationships between pain intensity, cognitive factors, and disability at 3 and 6 months postbaseline differ as a result of personality type, hierarchical regressions were performed for the DHA and NE groups separately. Within this study, disability was used as the outcome variable; age, sex, pain duration, and baseline disability were entered in step 1; pain intensity was entered in step 2; and the baseline cognitive variables were entered in step 3. All tests were conducted on both the 3-and 6-month data. In order to assess whether personality type moderates the relationship between disability and psychological variables, a moderation analysis was performed using the PROCESS macro. 28 
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The MCIC from baseline to 3 and 6 months for disability and pain intensity were calculated for the DHA and NE groups separately. Based on previous research, the MCIC for pain intensity was considered to be a reduction of 2 points 29 and for disability a reduction of 3 points on the RDQ. 12 
RESULTS
A statistical heterogeneity check confirmed that the DHA and NE groups were significantly different on measures of both defensiveness (t(53) = 6.56, P < 0.05) and trait anxiety (t(53) = 2.92, P < 0.05). An attrition analysis was run to identify any differences in baseline characteristics between participants who completed the 6-month follow-up questionnaires compared to those who did not. No significant differences were found in age (t(77) = 0.56, P = 0.956), sex (t(577) = 0.76, P = 0.44), pain duration (t(77) = 0.07, P = 0.95), pain intensity (t(77) = 0.37, P = 0.71), disability (t (77) = 0.47, P = 0.64), catastrophizing (t(77) = 0.83, P = 0.41), depression (t(77) = À0.22, P = 0.83), selfefficacy (t(77) = À0.39, P = 0.70), or kinesiophobia (t (77) = À0.11, P = 0.91).
Patient Characteristics
The repeated-measures ANOVA for disability revealed there was no effect of time, but there was a significant interaction effect between time and personality type (F (1, 31) = 4.53, P = 0.23). Follow-up t-tests revealed there was a nonsignificant trend of DHA individuals reporting higher baseline disability compared to NE individuals (t(31) = 1.84, P = 0.07; r = 0.4). Furthermore, the DHA group demonstrated significant reductions in disability (t(19) = 2.19, P < 0.05; r = 0.5) from baseline to 3 and 6 months (t(15) = 2.29, P < 0.05; r = 0.5). There were no significant changes in disability over time for the NE individuals. Of the cognitive factors, only catastrophizing demonstrated a significant interaction effect between time and personality type (F(1, 31) = 3.26, P = 0.04). Post hoc t-tests revealed that at baseline DHA individuals reported significantly higher catastrophizing compared to NE individuals (t(31) = 2.45, P < 0.05; r = 0.4). Within-group analysis revealed that the DHA individuals had significant reductions in depression from baseline to 3 months (t(19) = 2.86, P < 0.01; r = 0.5) and from baseline to 6 months (t(15) = 2.39, P < 0.05; r = 0.5).
Regression Analysis
Preliminary Examination of the Data. None of the correlation coefficients exceeded 0.90, indicating the data were not affected by singularity. Durbin-Watson values (1 to 3), variance inflation factors (~10), and tolerances (~0.10) were within acceptable limits for all regression analyses, suggesting that the assumption of independent errors was met. The predictor variables used in each of the regression analyses had variance inflation factors that were considerably less than 10 and tolerance levels that were higher than 0.2, indicating no problems with multicollinearity.
Analysis 1. Predicting 3-Month Disability from Baseline
Cognitive Factors in the Defensive High-Anxious Group -Age, sex, and pain duration were not significantly related to levels of disability; however, baseline disability was related to levels of disability at 3 months (P = 0.04). In step 2, current pain intensity was not related to the variance in disability (P = 0.09). After controlling for the effects of demographics and pain intensity, the cognitive factors explained an additional 28% (P < 0.01) of the variance in disability. Examination of the b values (Table 2) revealed that higher baseline disability (b = 0.71, P < 0.01) and kinesiophobia (b = 0.29, P < 0.05) and lower self-efficacy (b = À0.58, P < 0.05) were related to greater levels of disability. Depression and catastrophizing were not significantly linked.
Analysis 2. Predicting 6-Month Disability from Baseline
Cognitive Factors in the Defensive High-Anxious Group -As at 3 months, age, sex, and pain duration were not significantly related to levels of disability (P = 0.52), and baseline disability was no longer related. In step 2, current pain intensity was not related to the variance in disability (P = 0.14). After controlling for the effects of demographics and pain intensity, the cognitive factors explained an additional 30% (P < 0.05) of the variance in disability. Examination of the b values (Table 3) revealed that higher kinesiophobia (b = 0.49, P < 0.05) was related to greater levels of disability; however, selfefficacy was no longer significantly linked.
Analysis 3. Predicting 3-Month Disability from Baseline
Cognitive Factors in the Nonextreme Group -In step 1, age and baseline disability were significantly related to levels of disability (P < 0.01) and explained 80% of the variance. In step 2, current pain intensity was not related to levels of disability (P = 0.86). After controlling for the effects of demographics and pain intensity, the cognitive factors did not explain the variance in disability at 3 months. Examination of the b values (Table 4) revealed that lower age (b = À0.31, P < 0.05) and higher baseline disability (b = 0.68, P < 0.01) were associated with higher levels of disability.
Analysis 4. Predicting 6-Month Disability from Baseline
Cognitive Factors in the Nonextreme Group - Table 5 shows that in step 1, only baseline disability was significantly related to levels of disability at 6 months (b = 0.60, P < 0.05). Similarly, in steps 2 and 3, neither pain intensity nor the cognitive factors offered any significant relation to the variance in disability.
Moderation Analysis
3 Months. To test whether personality type moderates the relationship between baseline psychological variables and 3-month disability, a hierarchical multiple regression analysis with interaction terms was conducted. In step 1, the psychological variables, baseline disability, and personality type were added. These variables accounted for a significant amount of variance in disability (R 2 = 0.756, F(6, 35) = 18.06, P = 0.000).
To avoid high multicollinearity with the interaction term, the variables were centered, and interaction terms between the psychological variables, baseline disability, and personality type were created. Next, the interaction term between baseline disability, psychological variables, and personality type was added into the regression model. Self-efficacy and baseline disability accounted for a significant amount of variance in disability levels at 3 months (ΔR 2 = 0.08, ΔF(5, 30) = 13.95, P = 0.027; self-efficacy b = 0.64, t (38) = 1.08, P = 0.00; baseline disability b = À0.16, t (38) = À0.35, P = 0.000).
6 Months. To test whether personality type moderates the relationship between baseline disability, psychological variables, and 6-month disability, a second hierarchical multiple regression analysis with interaction terms was conducted. In step 1, the psychological variables, baseline disability, and personality type were added. These variables accounted for a significant amount of variance in disability (R 2 = 0.756, F(6, 26) = 18.06, P = 0.000).
Next, the interaction term between baseline disability, psychological variables, and personality type was added into the regression model. Catastrophizing and kinesiophobia accounted for a significant amount of variance in disability levels at 6 months (ΔR² = 0.08, ΔF (5, 21) = 6.47, P = 0.027; catastrophizing b = 0.04, t (29) = 0.20, P = 0.00; kinesiophobia b = À0.83, t (38) = À3.51, P = 0.00).
Responders and Nonresponders
Pain Intensity. A comparison of the baseline to 3-month and baseline to 6-month MCIC for pain intensity (improvement = À2 points) 29 is demonstrated in Fig- ure 2 for the DHA and NE groups. Both the DHA group (25%) and NE group (23%) had similar proportions of responders for reduced pain intensity from baseline to 3 months. In contrast, at 6 months, the DHA group demonstrated a greater proportion (38%), achieving an MCIC in pain intensity. Within the NE group, there was relatively little change, with only 24% having an MCIC.
Disability. A comparison of the baseline to 3-month and baseline to 6-month MCIC for disability (improvement = À3 points) 30 is demonstrated in Figure 3 for the DHA and NE groups. Of the DHA individuals, 35% had lower disability at 3 months compared to baseline, in contrast to only 14% of the NE individuals. The proportion of DHA individuals continued to improve, with 50% having an MCIC from baseline to 6 months. The NE individuals continued to show little change, with only 6% of the group having lower disability at 6 months compared to baseline.
DISCUSSION
The results from this study highlight the importance of considering personality type in the management and assessment of chronic pain. Within the DHA group, selfefficacy and kinesiophobia had a greater influence on disability. In contrast, the NE group's levels of disability were not influenced by pain intensity or by psychological factors, and only baseline disability affected the variance at 3 and 6 months. The moderation analysis highlights that personality type influences the relationship between baseline disability and self-efficacy and disability at 3 months. At 6 months, personality type moderates the relationship between disability and catastrophizing and kinesiophobia. DHA individuals reported greater improvement for both pain intensity and disability and showed stronger links between improvements in pain and disability and baseline psychological factors than the NE individuals. The majority of research within chronic pain populations has investigated the population as either a single homogenous group or stratified only based on levels of anxiety. The moderation analysis and regressions demonstrated that the cognitive factors had a different influence on disability depending on personality type. For the NE group, cognitive factors did not influence levels of disability at 3 or 6 months. In contrast, within the DHA group, the cognitive factors (lower self-efficacy and higher kinesiophobia) explain 28% of the variance in disability at 3 months and 30% (higher kinesiophobia) at 6 months. The significant influence of selfefficacy is consistent with previous research in chronic pain populations, which has identified self-efficacy to be a robust predictor for long-term outcome for perceived disability. 31 Conceptually, self-efficacy is related to Behaviorist Theory and refers to the way individuals set goals and the anticipation of outcome. 32 The extent to which patients are disabled by pain may depend on their level of self-efficacy, whereby patients with higher self-efficacy may more easily find strategies to prevent further recurrences. Individuals with lower self-efficacy may be more likely to avoid particular situations, a pattern that has been associated with helplessness and pessimistic thoughts. 33 DHA individuals have previously been found to be more pessimistic about outcome in high state anxiety situations than other personality types and to experience an amplified sense of threat to ambiguous situations. 34, 35 Their negative interpretation of such situations may reduce the likelihood that they will engage in physical activities that they perceive will be harmful or to report higher levels of disability. The DHA individuals reported higher levels of catastrophizing compared to the NE individuals. Furthermore, within the DHA group, kinesiophobia was found to influence disability at both 3 and 6 months. In line with the fear-avoidance model, Woby et al. 25 suggested that when there is a reduction in functional self-efficacy, higher fear of movement, and catastrophizing, individuals are more likely to avoid certain activities, which ultimately leads to greater disability, disuse, and depression. This may be further exacerbated within the DHA group as they are more likely to attend to threatening information and to see greater threat in ambiguous situations. Graded exposure to activities that may be perceived as threatening or harmful has been shown to be an effective treatment. 36, 37 This type of intervention may be particularly beneficial for DHA individuals, as it reduces fear of movement and improves self-efficacy with particular tasks and promotes more effective coping strategies. This may help clinicians to better target interventions and potentially decrease the rate of sick leave and influence adjustment to chronic pain, leading to lower healthcare utilization. 38 By contrast, the NE group showed no link between cognitive factors and disability. In this group, there is a less predictable relation between disability and cognitive factors. Because the PMPs tend to focus upon addressing the ways that patients perceive their pain and at improving self-efficacy, it is not altogether unsurprising that this personality group demonstrated relatively little response to the intervention as these factors are not significantly related to their disability.
The primary goal of treatment is to see an improvement in patients' pain intensity and disability, resulting in an improvement in daily living. Studies have investigated the MCIC to the patient, 12,39,40 using standard outcome measures such as pain intensity and disability. A higher proportion of the DHA individuals demonstrated an improvement in disability compared to the NE group from baseline to 3 months (DHA = 35%; NE = 14%) and baseline to 6 months (DHA = 50%; NE = 6%). Interestingly, from baseline to 3 months, both the DHA and NE groups had a similar percentage of individuals who improved in pain intensity (DHA = 25%; NE = 23%). From baseline to 6 months, the proportion of DHA individuals continued to increase; however, there was no change for the NE group (DHA = 38%; NE = 24%).
The majority of studies investigating clinical interventions analyze group differences between treatment and control conditions, whereby it is assumed that if there is no difference in the means, or the mean is less than the MCIC, then the treatment effect is unimportant. We can see that by stratifying the population by personality type, more of the DHA individuals perceive an improvement compared to the NE individuals. The NE individuals did not have any significant changes in their cognitive factors compared to the DHA group, who reported significant reductions in depression at both time points. Previous research has shown that changes in depression from pre-to post-treatment account for a significant amount of variance in changes in disability. 41 In addition, comorbid depression and chronic pain have been associated with more pain complaints, functional limitations, and greater healthcare utilization. 42, 43 The DHA individuals may be reporting lower depression and better outcome over time because, as treatment progresses, it is becoming effective by addressing cognitive factors. Current PMPs do not focus on directly reducing pain intensity but are based on cognitive-behavioral principles to improve coping strategies, potentially resulting in reductions in pain intensity and disability. Other cognitive elements such as depression, self-efficacy, and kinesiophobia have been shown to influence pain behavior and pain intensity, 43 which are factors that, within this study, influence the disability of DHA individuals over time. In contrast, within the NE group, psychological factors were not influential on their levels of disability. The moderation analysis highlighted that cognitive factors (eg, selfefficacy, kinesiophobia, and catastrophizing) are moderated by personality type. Compared to the NE group, DHA individuals have an enhanced attention towards pain-related information. Research within depression literature suggests that biased attention has an indirect influence on memory through its impact on interpretation biases, 44 whereby enhanced attention to negative information results in extensive elaboration and biased interpretation. This attributed meaning is likely to be stored within the long-term memory as a negative bias. Therefore, interventions focused on addressing cognitive elements may be more beneficial for DHA individuals compared to the NE group. There are some limitations within this study, which should be considered. Firstly, data were based on selfreport measures, which are potentially subject to bias and shared method variance. This study, however, explored the role of cognitive factors, which can only be measured by self-report. Secondly, there was no objective measure of disability; the study relied solely on self-report measures. A further limitation is the small number of repressors, high-anxious individuals, and low-anxious individuals, which meant they had to be excluded from the longitudinal analysis. This prevented a more detailed comparison between all personality types at each time point. A further consideration is the modest sample size within the regressions. Some caution should be taken in interpreting the results when the population is split based on personality type, although effect sizes support the interpretations offered.
The differences between the DHA and NE personality types highlight the need for defensiveness to be included in future assessments of individuals with chronic pain. The distinct differences between the 2 groups also have important implications for assessing the effectiveness of treatment. There is a potential paradox within the DHA individuals, who have previously been found to attend to pain-related information; however, a higher percentage of individuals report an improvement in their levels of disability. These responses can only be partially explained by the individual's cognitive biases. Other factors may include treatment type, environment (eg, family support), and behavior (eg, readiness to self-manage). Based on the recommended outcome measures 45 used in this study, it could be suggested that current treatment is more effective for DHA individuals compared to the NE group. Their improvement may have been quicker or more pronounced if they were not attending to their pain and experiencing negative affect, which in turn influences their behavior (eg, avoidance of activities). Differentiating these 2 groups may allow for more targeted and cost-effective interventions.
